SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
____________________________________
Date of report (Date of earliest event reported): December
4, 1997
CARDIAC SCIENCE, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-19567
33-0465681
(State or Other Juris- (Commission File
No.) (IRS Employer
diction of Incorporation)
Identification No.)
1176 Main Street, Suite C, Irvine, CA
92614
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(714) 587-0357
(Former Name or Former Address, if Changed Since
Last Report.)
ITEM 9. Sales of Equity Securities Pursuant to
Regulation S.
On December 4, 1997, Cardiac Science, Inc. (the
"Corporation") consummated a private placement of
250,000 shares of common stock, par value $0.001 per
share (the "Common Stock"), to various foreign investors
pursuant to Regulation S promulgated under the Securities
Act of 1933, as amended. The gross proceeds of the
offering totalled $500,000. In connection with the
offering, the Corporation paid an advisory fee of $25,000
and 12,500 shares of Common Stock to Sorbus Asset
Strategies, S.A., a Swiss company.
<PAGE>
Signatures:
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned
thereunto duly authorized.
CARDIAC SCIENCE, INC.
By: /s/ Raymond W. Cohen
Raymond W. Cohen, President and Chief
Executive Officer
Date: December 12, 1997
